GO Term | Evidence Code | PMID |
---|---|---|
determination of liver left/right asymmetry | ||
metanephric ascending thin limb development | ||
cellular response to calcium ion | ||
branching involved in ureteric bud morphogenesis | ||
embryonic placenta development |
GO Term | Evidence Code | PMID |
---|---|---|
basal cortex | ||
motile cilium | ||
ciliary basal body | ||
endoplasmic reticulum | ||
cytosol |
GO Term | Evidence Code | PMID |
---|---|---|
cytoskeletal protein binding | ||
ATPase binding | ||
monoatomic cation channel activity | ||
calcium channel activity | ||
muscle alpha-actinin binding |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:3910 | lung adenocarcinoma | |
DOID:3953 | adrenal gland cancer | |
DOID:4896 | bile duct adenocarcinoma | |
DOID:4897 | bile duct carcinoma | |
DOID:4928 | intrahepatic cholangiocarcinoma | |
DOID:4947 | cholangiocarcinoma | |
DOID:5076 | mixed glioma | |
DOID:557 | kidney disease | |
DOID:6000 | congestive heart failure | |
DOID:65 | connective tissue disease |
HPO ID | HPO Term |
---|---|
HP:0003259 | Elevated circulating creatinine concentration |
HP:0003596 | Middle age onset |
HP:0003621 | Juvenile onset |
HP:0003676 | Progressive |
HP:0003774 | Stage 5 chronic kidney disease |
HP:0003829 | Typified by incomplete penetrance |
HP:0004944 | Dilatation of the cerebral artery |
HP:0005562 | Multiple renal cysts |
HP:0006254 | Elevated circulating alpha-fetoprotein concentration |
HP:0006557 | Polycystic liver disease |
Disease ID | Disease Name |
---|---|
ORPHA:730 |
|
OMIM:613095 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
100411856 | CALJA29362 | ||
105576752 | CERAT13448 | ||
702179 | MACMU36998 | ||
105479647 | MACNE18355 | ||
101016289 | PAPAN28490 | ||
101141005 | GORGO30814 | ||
461367 | PANTR34093 | ||
100462082 | PONAB27608 | ||
112919562 | VULVU11866 | ||
101672143 | MUSPF11963 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024